Ordenar

Buscar

01/12/2025 Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trial
Salinas, P, Romaguera, R, Gómez-Lara, J, Brugaletta, S, Gómez-Menchero, A, Martín, P, Romero, M, García-Blas, S, Jiménez, M, Jiménez, VA, Bordes, P, Bayón, J, Salvatella, N, Alameda, M, Hyun-Lee, D, Trillo-Nouche, R, López-Benito, M, Frutos, A, Moreu, J, del Blanco, BG, Mohandes, M, Ojeda, FB, Hernández, FH, Pinar-Bermúdez, E, Jiménez-Quevedo, P, Rosselló, X, Pocock, S, Sabaté, M, Gómez-Hospital, JA, Comin-Colet, J, Gonzalo, N, Ortiz, AF, SUGAR Trial Investigators. Amphilimus-eluting versus zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: extended follow-up of the SUGAR randomised controlled trial. HEART. 2025; 111(24)DOI:10.1136/heartjnl-2025-325773. PMID:40562528. IF:4.400(Q1/3D).
01/12/2025 Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference
Svennberg, E, Merino, JL, Andrade, J, Anselmino, M, Arbelo, E, Boersma, E, Boriani, G, Breithardt, G, Chung, MN, Chyou, J, Cohen, A, Nielsen, JC, Dichtl, W, Diederichsen, SZ, Dobrev, D, Doehner, W, Dworatzek, E, Fabritz, L, Filgueiras-Rama, D, Gimpelewicz, C, Hack, G, Hatem, S, Healey, J, Heidbuchel, H, Hijazi, Z, Holst, AG, Hove-Madsen, L, Jalife, J, van Leerdam, R, Linz, D, Lip, GYH, Lubitz, S, de Melis, M, Meyer, R, Orczykowski, M, Parwani, AS, Porta-Sanchez, A, de Potter, T, Ravens, U, Rienstra, M, Rillig, A, Rivard, L, Scherr, D, Schnabel, RB, Schotten, U, Simovic, S, Sinner, M, Sohns, C, Sommer, P, Steinbeck, G, Steven, D, Sultan, A, Thomalla, G, Toennis, T, Tzeis, S, Voigt, N, Wadhwa, M, Wakili, R, Witt, H, Goette, A, Kirchhof, P. Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference. EUROPACE. 2025; 27(12)DOI:10.1093/europace/euaf318. PMID:41392710. IF:7.400(Q1/2D).
01/12/2025 Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesions
Vizarraga, D, Marcos, M, Rotllan, N, Martín, J, Santos, D, Camacho, M, Soto, B, Velasco-Reniu, L, Guerra, P, Pareja, F, Collantes, M, Wu, WL, Rodríguez-Arce, I, Serrano, L, Piñol, J, Fita, I, Escolà-Gil, JC. Sources of essential lipids for Mycoplasma pneumoniae via P116 to target liver and atherosclerotic lesions. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-66129-5. PMID:41402265. IF:15.700(Q1/1D).
01/12/2025 Baseline Plasma Protein Signatures and Differential Molecular Responses to Dupilumab in Atopic Dermatitis Patients
Serra, E, Cantó, E, Gely, C, Pont, M, Trincado, J, Crespo, M, Vidal, S, Puig, L. Baseline Plasma Protein Signatures and Differential Molecular Responses to Dupilumab in Atopic Dermatitis Patients. JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2025; 145(12)DOI:. PMID:. IF:5.700(Q1/1D).